India to require all changes in delivery to be regulated as a new drug

India's health ministry is amending its rule for drug delivery systems to require any change in delivery method to undergo the full regulatory process of a new drug. This includes modified release dosages, according to a PharmaBiz report, because changes in the delivery method can affect both efficacy and toxicity. More

Suggested Articles

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

It’s not exactly going to be smooth sailing for Allergan’s multidose bottle version of dry-eye med Restasis. As it finally gets the green light from the FDA, a…

Counting on a novel nasal-spray device to set it apart from its rivals, drug delivery specialist OptiNose is preparing to file its new chronic rhinosinusitis…